RecruitingPHASE1, PHASE2NCT07287397
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Studying Amyotrophic Lateral Sclerosis (ALS)
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vector Y Therapeutics
- Intervention
- VTx-002(genetic)
- Enrollment
- 12 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (11)
- St Joseph's Hospital and medical Center - Barrow Neurological Institute, Phoenix, Arizona, United States
- University of California San Diego Medical Center, San Diego, California, United States
- Mayo Clinic in Florida, Jacksonville, Florida, United States
- University of Miami School of Science, Miami, Florida, United States
- Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, Boston, Massachusetts, United States
- Herbert Irving Comprehensive Cancer Center, New York, New York, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- UZ Leuven, Leuven, Belgium
- UMC Utrecht, Utrecht, Netherlands
- Kings College Hospital, London, United Kingdom
- Royal Hallamshire Hospital, Sheffield, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07287397 on ClinicalTrials.govOther trials for Amyotrophic Lateral Sclerosis (ALS)
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07017946Intestinal Microbiome Transplant in ALSDuke University
- ENROLLING BY INVITATIONNANCT07539662Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)Institute of Hematology & Blood Diseases Hospital, China
- ACTIVE NOT RECRUITINGPHASE2NCT07023835Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral SclerosisZydus Therapeutics Inc.
- RECRUITINGNANCT07413718Inspiratory Muscle Training in Amiotrophyc Lateral SclerosisUniversity Ramon Llull
- RECRUITINGPHASE1NCT06665165AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisAmylyx Pharmaceuticals Inc.
- RECRUITINGNANCT06609213Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALSAndrea Charvet
- RECRUITINGNANCT06249412The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS PatientsGroupe Hospitalier du Havre
- RECRUITINGNANCT06834269Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.Campus Bio-Medico University